Trevi Therapeutics TRVI Q1 2026 Disappoints EPS 009 Below 008 Views Silo Pharma SILO Q4 2023 Earnings Miss Sparks Concern Trumps Approval Rating Drops to 35 as Republican Support Weakens Potential Market Implications Ola Electric Q4 Results 2026 Net Loss Seen Narrowing Revenue May Slump 45 YoY